Filing Flows › Comparisons › OPCH vs CHE
Option Care Health vs Chemed: OPCH and CHE compared
Option Care Health is the larger company: $1.5B of revenue in its latest quarter (Q3 2026) against $691M for Chemed (Q3 2026). Chemed is growing faster (+11% against +4% a year earlier). Chemed is more profitable, with an operating margin of 14.0% against 6.0%.
Where the money goes: OPCH and CHE
Option Care Health (OPCH) · Q3 2026
Option Care Health, Q3 2026: revenue $1.5B (+4% year over year), operating margin 6.0%, net earnings $57.4M, operating cash flow $115M. The chart follows the revenue to costs, profit and cash.
Chemed (CHE) · Q3 2026
Chemed, Q3 2026: revenue $691M (+11% year over year), operating margin 14.0%, net earnings $71.6M, operating cash flow $56.6M. The chart follows the revenue to costs, profit and cash.
| Option Care Health (OPCH) | Chemed (CHE) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 2026 |
| Revenue | $1.5B | $691M |
| Revenue growth, Y/Y | +4% | +11% |
| Gross margin | 19.1% | — |
| Operating margin | 6.0% | 14.0% |
| Net earnings | $57.4M | $71.6M |
| Net margin | 3.8% | 10.4% |
| Operating cash flow | $115M | $56.6M |
| Free cash flow | $108M | $37.9M |
| Market value | $4.8B | $6.9B |
| P/E | 22.9× | 25.3× |
| Analysts’ mean target | $30.03 | $617.00 |
Where the revenue comes from
Chemed
- VITAS: $457M (66%)
- Roto-Rooter: $234M (34%)
Questions
Which is bigger, Option Care Health or Chemed?
Option Care Health is the larger company: $1.5B of revenue in its latest quarter (Q3 2026) against $691M for Chemed (Q3 2026).
Is Option Care Health or Chemed growing faster?
Chemed is growing faster (+11% against +4% a year earlier).
Which is more profitable, Option Care Health or Chemed?
Chemed is more profitable, with an operating margin of 14.0% against 6.0%.
More: Option Care Health earnings · how Option Care Health makes money · Chemed earnings · how Chemed makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 4, 2026; 10-Q filed Oct 29, 2026). Fiscal quarters can end on different dates. Not investment advice.